Gonorrhea & Chlamydia
Rectal & Pharyngeal
Nucleic Acid Amplified Testing
Simple Swab Screening. No Culture Necessary.
A recent study* in men who have sex with men found that approximately 85% of rectal GC and CT infections are asymptomatic, supporting the need for routine screening.
Chlamydia trachomatis and Neisseria gonorrhoeae Testing by Nucleic Acid Amplification available from LabCorp and Quest Diagnostics.
Submit the Gen-Probe APTIMA® swab or urine transports for amplified detection of C. trachomatis (CT) and/or N. gonorrhoeae (GC) from rectal specimens, pharyngeal specimens, first-void urine specimens, male urethra swab specimens, or endocervical specimens. Both CT and GC tests can be performed from a single transport device.
Company- and Laboratory-Specific Ordering Codes for Combined GC/CT Nucleic Acid Amplified Tests
Relevant CPT Billing Codes:
CT detection by amplified nucleic acid probe technique = 87491
GC detection by amplified nucleic acid probe technique = 87591
*Kent, et al. Clinical Infectious Diseases 2005;41:67–74
This document is not an endorsement of any specific diagnostic laboratory company or product. Other commercial or non-commercial laboratories may offer similar or equivalent testing services. For most current ordering codes and specimen handling requirements, please consult your laboratory services provider.